Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Avalanche Biotech Raises US$55 Million In Series B Venture Financing 12
Partnerships 14
Adverum Biotechnologies Extends Agreement with Editas Medicine 14
Synpromics Expanded its Research Agreement with Adverum Biotech 15
Regeneron Pharma Enters Into Co-Development Agreement With Avalanche Biotech For Gene Therapy Products 16
Licensing Agreements 17
Avalanche Biotech Enters into Licensing Agreement with University of Washington 17
GenSight Biologics Enters into Licensing Agreement with Avalanche Biotech 18
Equity Offering 20
Adverum Biotech Raises USD69 Million in Public Offering of Shares 20
Adverum Biotech to Raise up to USD50 Million in Public Offering of Shares 22
Avalanche Biotechnologies Raises USD140 Million in Public Offering of Shares 23
Avalanche Biotech Completes IPO for USD117 Million 25
Avalanche Biotech Raises USD10 Million in Private Placement of Shares 27
Acquisition 28
Avalanche Biotech Acquires Annapurna Therapeutics 28
Adverum Biotechnologies Inc – Key Competitors 30
Adverum Biotechnologies Inc – Key Employees 31
Adverum Biotechnologies Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Aug 08, 2018: Adverum Biotechnologies reports second quarter 2018 financial results and provides corporate update 33
May 09, 2018: Adverum Biotechnologies Reports First Quarter 2018 Financial Results and Provides Corporate Update 35
Mar 06, 2018: Adverum Biotechnologies Reports Fourth Quarter 2017 Financial Results and Provides Corporate Update 37
Nov 08, 2017: Adverum Biotechnologies Reports Third Quarter 2017 Financial Results and Provides Corporate Update 39
Aug 08, 2017: Adverum Biotechnologies Reports Second Quarter 2017 Financial Results and Provides Update 40
May 09, 2017: Adverum Biotechnologies Reports First Quarter 2017 Financial Results and Provides Update 41
Mar 06, 2017: Adverum Biotechnologies Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Update 42
Corporate Communications 44
Oct 17, 2018: Adverum Biotechnologies Announces Appointment of Leone Patterson as CEO and Member of the Board of Directors 44
May 03, 2018: Adverum Biotechnologies Announces Leadership Changes 45
Sep 07, 2017: Adverum Biotechnologies Appoints Eric G. Carter, M.D., Ph.D. to Board of Directors 46
Jun 20, 2017: Adverum Biotechnologies appoints senior vice president and chief medical officer 47
Apr 20, 2017: Adverum Biotechnologies Appoints Richard N. Spivey, Pharm.D., Ph.D. to Board of Directors 48
Mar 14, 2017: Adverum Biotechnologies Appoints Patrick Machado, J.D. to Board of Directors 49
Product News 50
Aug 01, 2018: Adverum Biotechnologies announces clinical progress across gene therapy Pipeline 50
Product Approvals 52
Jan 04, 2018: Adverum Biotechnologies Provides Update on its Hereditary Angioedema Drug Candidate ADVM-053 52
Other Significant Developments 53
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Adverum Biotechnologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Avalanche Biotech Raises US$55 Million In Series B Venture Financing 12
Adverum Biotechnologies Extends Agreement with Editas Medicine 14
Synpromics Expanded its Research Agreement with Adverum Biotech 15
Regeneron Pharma Enters Into Co-Development Agreement With Avalanche Biotech For Gene Therapy Products 16
Avalanche Biotech Enters into Licensing Agreement with University of Washington 17
GenSight Biologics Enters into Licensing Agreement with Avalanche Biotech 18
Adverum Biotech Raises USD69 Million in Public Offering of Shares 20
Adverum Biotech to Raise up to USD50 Million in Public Offering of Shares 22
Avalanche Biotechnologies Raises USD140 Million in Public Offering of Shares 23
Avalanche Biotech Completes IPO for USD117 Million 25
Avalanche Biotech Raises USD10 Million in Private Placement of Shares 27
Avalanche Biotech Acquires Annapurna Therapeutics 28
Adverum Biotechnologies Inc, Key Competitors 30
Adverum Biotechnologies Inc, Key Employees 31
Adverum Biotechnologies Inc, Subsidiaries 32
List of Figures
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Adverum Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9